RondinX

Company Overview

Snapshot

Founded in May 2015 by Guy Harmelin, Rafi Gidron, and Alon Hirsch, RondinX operated with 1–10 employees. The company raised $2.5 million across one funding round from two investors before being acquired by BiomX in December 2017.

Business overview

RondinX developed a target and drug discovery platform focused on creating solutions within the microbiome therapeutic and companion diagnostic sectors. The company's core technology, exclusively licensed from YEDA (the commercial arm of the Weizmann Institute of Science), utilized a proprietary, cloud-based computational pipeline. This system processed raw metagenomics data to generate both static and dynamic strain-level insights into the bacterial ecosystem, serving the Health Tech & Life Sciences sector, particularly in pharmaceuticals and drug discovery and development.

Strategic signal

In December 2017, BiomX acquired RondinX to enhance its microbiome discovery and development capabilities. This acquisition signaled a strategic move by BiomX to integrate RondinX's computational platform and expertise, aiming to accelerate innovation in microbiome therapeutics and diagnostics within the biotechnology industry.

Company Intelligence Q&A

What is RondinX's primary focus?

RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces, leveraging its proprietary computational pipeline.

When was RondinX founded and by whom?

RondinX was founded in May 2015 by Guy Harmelin, Rafi Gidron, and Alon Hirsch.

What was a significant development for RondinX in January 2017?

In January 2017, RondinX expanded its microbiome computational platform for drug development with a unified reference range of bacterial dynamics, based on a database of 1,400 healthy individuals.

What was the outcome for RondinX in December 2017?

In December 2017, RondinX was acquired by BiomX to boost its microbiome discovery and development capabilities, leading to RondinX's inactive status.

What technology underpins RondinX's platform?

RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science. This proprietary, cloud-based computational pipeline uses raw metagenomics to derive strain-level insights into the bacterial ecosystem.